Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FGF21: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FGF21 encodes a metabolic regulator of the FGF19 subfamily with emerging roles in neuroprotection, neuroinflammation, synaptic plasticity, and potential therapeutic applications in Alzheimer's and Parkinson's diseases.
| Gene Symbol | FGF21 |
| Full Name | Fibroblast Growth Factor 21 |
| Chromosome | 12q13 |
| Function | encodes a member of the FGF19 subfamily of fibroblast growth factors that functions primarily as a metabolic regulator. |
| Molecular Weight | 22.5 kDa |
| Amino Acids | 209 aa |
| Pathways | Apoptosis, Autophagy, Mtor |
| UniProt ID | Q9NS73 |
| NCBI Gene ID | 26291 |
| Ensembl ID | ENSG00000163410 |
| OMIM | 609436 |
| GeneCards | FGF21 |
| Human Protein Atlas | FGF21 |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis Survival, Diabetes, Fibrosis |
| Known Drugs/Compounds | metformin |
| Interactions | ULK1, KDM6B, LC3, ATG7, FNDC5, PLAU |
| KG Connections | 504 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
FGF21["FGF21<br/>Fibroblast Growth<br/>Factor 21"]
FGFR1["FGFR1<br/>FGF Receptor 1"]
JMJD3["JMJD3<br/>Histone Demethylase"]
LipidCat["Lipid Catabolism<br/>Metabolic Process"]
Inflammation["Inflammation<br/>Immune Response"]
Neuroinflam["Neuroinflammation<br/>CNS Inflammation"]
ALS["ALS<br/>Amyotrophic Lateral<br/>Sclerosis"]
MS["Multiple Sclerosis<br/>Demyelinating<br/>Disease"]
Stroke["Stroke<br/>Cerebrovascular<br/>Disease"]
Ischemia["Ischemia<br/>Reduced Blood Flow"]
Aging["Aging<br/>Cellular Senescence"]
Senescence["Senescence<br/>Age-related<br/>Decline"]
Fibrosis["Fibrosis<br/>Tissue Scarring"]
Diabetes["Diabetes<br/>Metabolic<br/>Dysfunction"]
FattyLiver["Fatty Liver<br/>Hepatic Steatosis"]
FGF21 --|"interacts with"|--> FGFR1
FGF21 --|"activates"|--> JMJD3
FGF21 --|"promotes"|--> LipidCat
FGF21 --|"biomarker for"|--> Inflammation
FGF21 --|"biomarker for"|--> ALS
FGF21 --|"biomarker for"|--> Aging
FGF21 --|"biomarker for"|--> Senescence
FGF21 --|"protects against"|--> Inflammation
FGF21 --|"protects against"|--> Neuroinflam
FGF21 --|"prevents"|--> FattyLiver
FGF21 --|"therapeutic target"|--> Stroke
FGF21 --|"therapeutic target"|--> MS
FGF21 --|"therapeutic target"|--> Fibrosis
Inflammation --|"leads to"|--> Neuroinflam
Neuroinflam --|"contributes to"|--> ALS
Neuroinflam --|"contributes to"|--> MS
Ischemia --|"triggers"|--> Stroke
style FGF21 fill:#006494
style FGFR1 fill:#4a1a6b
style JMJD3 fill:#4a1a6b
style LipidCat fill:#1b5e20
style Inflammation fill:#ef5350
style Neuroinflam fill:#ef5350
style ALS fill:#5d4400
style MS fill:#5d4400
style Stroke fill:#5d4400
style Aging fill:#ef5350
style Fibrosis fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| Hepatic Autophagy | activates | process | 0.95 |
| Subarachnoid Hemorrhage | protects_against | disease | 0.95 |
| Septic Liver Injury | treats | phenotype | 0.95 |
| Proinflammatory Macrophage Activation | inhibits | process | 0.95 |
| Septic Liver Injury | associated_with | disease | 0.95 |
| Neuroinflammation | associated_with | process | 0.95 |
| Inflammation | suppresses | process | 0.95 |
| Lipid Degradation | activates | process | 0.92 |
| Parkinson's disease | protects_against | disease | 0.92 |
| cGAS-STING | inhibits | pathway | 0.90 |
| Mitophagy | associated_with | process | 0.90 |
| Autophagy | promotes | process | 0.90 |
| dopaminergic neuron survival | promotes | phenotype | 0.89 |
| microglia activation | modulates | process | 0.88 |
| PKA | activates | protein | 0.88 |
| mitochondrial homeostasis | promotes | process | 0.87 |
| Hepatosteatosis | modulates | phenotype | 0.85 |
| CGAS | inhibits | protein | 0.85 |
| STING | inhibits | protein | 0.85 |
| Diabetes-Associated Cognitive Impairment | mediates | disease | 0.85 |
| Non-alcoholic Fatty Liver Disease | treats | disease | 0.85 |
| Insulin Sensitivity | regulates | phenotype | 0.85 |
| Amyotrophic Lateral Sclerosis Survival | associated_with | phenotype | 0.85 |
| Muscle Atrophy | expressed_in | phenotype | 0.85 |
| Myogenesis | promotes | process | 0.85 |
| Sepsis | treats | disease | 0.85 |
| HIF-1α | modulates | protein | 0.85 |
| dopaminergic neuron | stimulates_differentiation | cell_type | 0.80 |
| autophagy pathway | participates_in | pathway | 0.80 |
| ERK1/2 | activates | pathway | 0.80 |
| ACE2 | interacts_with | gene | 0.80 |
| Stress-Induced Cytotoxicity | inhibits | process | 0.80 |
| Parkinson's Disease | associated_with | disease | 0.80 |
| MITOPHAGY | promotes | process | 0.80 |
| cGAS-STING pathway | inhibits | pathway | 0.80 |
| IL-6 | activates | gene | 0.80 |
| Als | activates | disease | 0.75 |
| Diabetes | activates | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Aging | therapeutic_target | disease | 0.75 |
| SOD1 | co_expressed_with | protein | 0.75 |
| Aging | modulates | process | 0.75 |
| JMJD3 | activates | protein | 0.72 |
| ULK1 | activates | gene | 0.70 |
| Synaptic Plasticity | activates | pathway | 0.70 |
| lipid catabolism | activates | process | 0.70 |
| FGFR1 | interacts_with | protein | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Fasting | activates | process | 0.90 |
| Methionine Restriction | activates | process | 0.90 |
| Dietary Restriction | modulates | process | 0.85 |
| BCAA | associated_with | chemical | 0.80 |
| EXERCISE | activates | gene | 0.80 |
| BDNF | activates | gene | 0.70 |
| AGING | therapeutic_target | gene | 0.70 |
| ATG7 | regulates | entity | 0.60 |
| AMPK | regulates | entity | 0.60 |
| ULK1 | activates | gene | 0.60 |
| CXCL10 | activates | gene | 0.60 |
| PLAU | activates | gene | 0.60 |
| FGF23 | activates | gene | 0.60 |
| APP | biomarker_for | gene | 0.60 |
| FGFR1 | activates | gene | 0.60 |
| ATG7 | activates | gene | 0.60 |
| GUSB | associated_with | gene | 0.60 |
| FOS | regulates | gene | 0.60 |
| HK2 | therapeutic_target | gene | 0.60 |
| LGALS3 | regulates | gene | 0.60 |
| RELA | regulates | gene | 0.60 |
| SOD2 | regulates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| GPNMB | biomarker_for | gene | 0.60 |
| CX3CL1 | activates | gene | 0.60 |
| PROGRANULIN | activates | gene | 0.60 |
| VIM | activates | gene | 0.60 |
| S100B | biomarker_for | gene | 0.60 |
| HMGB1 | biomarker_for | gene | 0.60 |
| TGM2 | biomarker_for | gene | 0.60 |
| VIMENTIN | activates | gene | 0.60 |
| C1Q | biomarker_for | gene | 0.60 |
| FNDC5 | activates | gene | 0.60 |
| TFEB | activates | gene | 0.60 |
| KDM6B | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| ANG | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| SIRT1 | protects_against | gene | 0.60 |
| SOD1 | activates | gene | 0.60 |
| SOD2 | activates | gene | 0.60 |
| HMOX1 | associated_with | gene | 0.60 |
| CGAS | activates | gene | 0.60 |
| NOX4 | activates | gene | 0.60 |
| PPAR | activates | gene | 0.60 |
| STING | activates | gene | 0.60 |
| PPAR | inhibits | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| ATF4 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||